29 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Atf2Tg(Gzma-Klra1)7Wum/Atf2+ involves: C57BL/6	abnormal artery development	J:134875
	abnormal NK cell physiology	J:61178
	decreased circulating interferon-gamma level	J:61178
	decreased NK cell number	J:61178
	decreased NK T cell number	J:61178
	normal immune system phenotype	J:61178
	increased metastatic potential	J:61178
Atf2tm1Nicj/Atf2tm1Nicj Atf7tm1Nicj/Atf7tm1Nicj involves: 129P2/OlaHsd * C57BL/6	abnormal common myeloid progenitor cell morphology	J:123909
	anemia	J:123909
	embryonic growth arrest	J:123909
	embryonic growth retardation	J:123909
	embryonic lethality during organogenesis, complete penetrance	J:123909
Atf2tm1Sis/Atf2+ Creb5tm1Sis/Creb5+ involves: C57BL/6 * CBA	abnormal cell differentiation	J:156376
	normal adipose tissue phenotype	J:156376
	normal behavior/neurological phenotype	J:156376
	decreased subcutaneous adipose tissue amount	J:156376
	decreased white adipose tissue amount	J:156376
	decreased white fat cell size	J:156376
	normal growth/size/body region phenotype	J:156376
	improved glucose tolerance	J:156376
	increased insulin sensitivity	J:156376
	increased oxygen consumption	J:156376
Atf2tm1Sis/Atf2tm1Sis Creb5tm1Sis/Creb5tm1Sis involves: C57BL/6 * CBA	abnormal cell differentiation	J:156376
Atf2tm2Nicj/Atf2tm2Nicj Atf7tm1Nicj/Atf7tm1Nicj involves: 129P2/OlaHsd * C57BL/6	abnormal common myeloid progenitor cell morphology	J:123909
	abnormal liver morphology	J:123909
	anemia	J:123909
	decreased cell proliferation	J:123909
	embryonic growth arrest	J:123909
	embryonic growth retardation	J:123909
	embryonic lethality during organogenesis, complete penetrance	J:123909
	heart hypoplasia	J:123909
	hemopericardium	J:123909
	increased apoptosis	J:123909
	increased hepatocyte apoptosis	J:123909
	liver hypoplasia	J:123909